Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by BullorBear46on Feb 26, 2017 11:00am
147 Views
Post# 25895197

U.S. Congress bill would empower states to set cannabis laws

U.S. Congress bill would empower states to set cannabis lawsLINK :https://news.lift.co/us-congress-considers-bill-empower-states-set-cannabis-laws/

QUOTE : 

Earlier this month a bill was introduced to the United States House of Representatives which, if approved, would mandate US federal agencies to respect the widely varying cannabis laws set by individual states.

While over thirty states have passed legislation making it legal to possess and/or sell cannabis for medical purposes—and with another eight states having legalized recreational use and sale as well—cannabis remains illegal at the federal level. The official position of the White House has traditionally been that because federal law supersedes state law, any cannabis businesses currently operating in the United States are doing so illegally, even if they adhere to the provisions of their local State law.

This has led to controversy in recent years as cannabis providers operating under the auspices of state laws are still threatened by raids from federal agencies. In December of 2014, the Obama administration passed a bill that removed the obligation for federal agencies to target cannabis offenses in states that have legalized medicinal marijuana. But despite this bill having been passed into law, federal agencies continue to raid cannabis businesses in states where medical use is legal, and the threat remains for shops in states where recreational use is legal.

That may be changing if recently introduced bill H.R.975, titled the “Respect State Marihuana Laws Act of 2017,” is approved by Congress. The new bill calls for an amendment to the Controlled Substances Act (CSA) pertaining to cannabis (or “marijuana” as it’s referred to in the CSA). If approved, the amendment would make the relevant subsection of the CSA “not apply to any person acting in compliance with state laws relating to the production, possession, distribution, dispensation, administration, or delivery of marihuana.”

That means in states where cannabis has been legalized at the state level, dispensaries and cannabis users would no longer have to fear being arrested and prosecuted by federal agencies as long as they adhere to the regulations set by their state law.

The new bill was introduced to the House by California Republican Rep. Dana Rohrabacher, but despite being introduced by a GOP member with the bipartisan support of over a dozen co-sponsors from both major parties, it faces the challenge of going against the narrative set by the White House. US Press Secretary Sean Spicer said in a recent statement that the Trump administration intends to respect individual State laws with regards to medical cannabis, but that recreational cannabis will continue to be prohibited.

This makes it likely Bill H.R.975 will need to be amended while in committee review, to apply only to medical cannabis, before it could be approved without garnering ire from the White House. But if the bill passes in either form, then for those to whom it applies, it would signal a change from being vulnerable to arrest from federal agents not required—but still able—to target them, to federal agents no longer having cannabis-related jurisdiction over them at all.

Currently the bill is being reviewed by the House Committee on Energy and Commerce, and is set to be voted on during the ongoing 2017-18 session of Congress.

– Scott Johnstone

Bullboard Posts